These 10 medtech companies care a lot about research

7. Accuray

R&D spending: $57,251,000

Percentage of revenues: 14.1%

2018 overall revenue ranking: 85

Accuray (Sunnyvale, Calif.) develops, manufactures and sells radiation oncology systems for shorter, safer and smarter cancer treatment options for multiple types of cancer. One of the significant technologies that the company touts on its website is the CyberKnife, which is a precise robotic treatment that is customizable for every patient.

The CyberKnife is used for stereotactic radiosurgery and stereotactic body radiation therapy and includes dynamic tracking and motion compensation. The system, according to Accuray, enables high precise, non-surgical treatment for tumors and lesions anywhere within the body, including the prostate, lung, brain, spine, liver, pancreas and kidney. The system also offers automatic, real-time tumor tracking and motion management to give more precise treatment of a variety of cancers, reducing the therapy’s impact on quality of life.

Next >>

Theranos whistleblower Tyler Shultz to participate in keynote interview at DeviceTalks Boston At DeviceTalks Boston, Tyler Shultz will give attendees an inside look at Theranos and how he was able to sound the alarm after he realized the company was falling apart. Shultz will take attendees behind the story that everyone is talking about: the rise and fall of Elizabeth Holmes and her diagnostic company, Theranos. Join Shultz and 1,000+ medical device professionals at the 8th annual DeviceTalks Boston. REGISTER NOW